Literature DB >> 30404033

Immunoglobulin E blockade during food allergen ingestion enhances the induction of inhibitory immunoglobulin G antibodies.

Amanda J Stranks1, Samantha C Minnicozzi2, Samuel J Miller3, Oliver T Burton2, Stephanie L Logsdon4, Jonathan M Spergel5, Kari C Nadeau6, Jacqueline A Pongracic7, Dale T Umetsu8, Rima Rachid2, Andrew J MacGinnitie2, Lynda C Schneider2, Hans C Oettgen9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30404033      PMCID： PMC6360101          DOI： 10.1016/j.anai.2018.10.024

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  10 in total

1.  Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.

Authors:  Calman Prussin; Daniel T Griffith; Kevin M Boesel; Henry Lin; Barbara Foster; Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

Review 2.  The mast cell IgG receptors and their roles in tissue inflammation.

Authors:  Odile Malbec; Marc Daëron
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

Review 3.  Food allergy.

Authors:  Harald Renz; Katrina J Allen; Scott H Sicherer; Hugh A Sampson; Gideon Lack; Kirsten Beyer; Hans C Oettgen
Journal:  Nat Rev Dis Primers       Date:  2018-01-04       Impact factor: 52.329

4.  A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

Authors:  Lynda C Schneider; Rima Rachid; Jennifer LeBovidge; Emily Blood; Mudita Mittal; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2013-10-28       Impact factor: 10.793

5.  Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.

Authors:  Oliver T Burton; Stephanie L Logsdon; Joseph S Zhou; Jaciel Medina-Tamayo; Azza Abdel-Gadir; Magali Noval Rivas; Kyle J Koleoglou; Talal A Chatila; Lynda C Schneider; Rima Rachid; Dale T Umetsu; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2014-07-16       Impact factor: 10.793

6.  Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.

Authors:  Lisa A Beck; Gregory V Marcotte; Donald MacGlashan; Alkis Togias; Sarbjit Saini
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

7.  Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells.

Authors:  Oliver T Burton; Magali Noval Rivas; Joseph S Zhou; Stephanie L Logsdon; Alanna R Darling; Kyle J Koleoglou; Axel Roers; Hani Houshyar; Michael A Crackower; Talal A Chatila; Hans C Oettgen
Journal:  Immunity       Date:  2014-07-10       Impact factor: 31.745

8.  Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy.

Authors:  Kari C Nadeau; Lynda C Schneider; Lisa Hoyte; Irene Borras; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

9.  IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.

Authors:  Alexandra F Santos; Louisa K James; Henry T Bahnson; Mohammed H Shamji; Natália C Couto-Francisco; Sabita Islam; Sally Houghton; Andrew T Clark; Alick Stephens; Victor Turcanu; Stephen R Durham; Hannah J Gould; Gideon Lack
Journal:  J Allergy Clin Immunol       Date:  2015-02-07       Impact factor: 10.793

10.  Omalizumab facilitates rapid oral desensitization for peanut allergy.

Authors:  Andrew J MacGinnitie; Rima Rachid; Hana Gragg; Sara V Little; Paul Lakin; Antonella Cianferoni; Jennifer Heimall; Melanie Makhija; Rachel Robison; R Sharon Chinthrajah; John Lee; Jennifer Lebovidge; Tina Dominguez; Courtney Rooney; Megan Ott Lewis; Jennifer Koss; Elizabeth Burke-Roberts; Kimberly Chin; Tanya Logvinenko; Jacqueline A Pongracic; Dale T Umetsu; Jonathan Spergel; Kari C Nadeau; Lynda C Schneider
Journal:  J Allergy Clin Immunol       Date:  2016-09-05       Impact factor: 10.793
  10 in total
  5 in total

Review 1.  Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.

Authors:  Laurent Guilleminault; Marine Michelet; Laurent Lionel Reber
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-22       Impact factor: 8.667

2.  Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab.

Authors:  Monali Manohar; Diane Dunham; Sheena Gupta; Zheng Yan; Wenming Zhang; Samantha Minnicozzi; Matthew Kirkey; Bryan Bunning; Roshni Roy Chowdhury; Stephen J Galli; Scott D Boyd; Laurie Elizabeth Kost; R Sharon Chinthrajah; Manisha Desai; Hans C Oettgen; Holden T Maecker; Wong Yu; Rosemarie H DeKruyff; Sandra Andorf; Kari C Nadeau
Journal:  Allergy       Date:  2021-05-29       Impact factor: 14.710

Review 3.  Mechanisms of oral immunotherapy.

Authors:  Suzanne M Barshow; Michael D Kulis; A Wesley Burks; Edwin H Kim
Journal:  Clin Exp Allergy       Date:  2021-01-20       Impact factor: 5.401

Review 4.  IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy.

Authors:  Cynthia Kanagaratham; Yasmeen S El Ansari; Owen L Lewis; Hans C Oettgen
Journal:  Front Immunol       Date:  2020-12-11       Impact factor: 7.561

Review 5.  B cells and the microbiota: a missing connection in food allergy.

Authors:  Evelyn Campbell; Lauren A Hesser; Cathryn R Nagler
Journal:  Mucosal Immunol       Date:  2020-10-26       Impact factor: 8.701
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.